Qihan Biotech：In vivo CAR-T clinical data were disclosed by Qihan Biotech.
Lupeng：Rocbrutinib received marketing approval
Jiangsu Vcare：VC004 injection approved via priority review.
Otsuka Pharmaceutical：VoyxactSibeprenlimab was approved through the priority review process.
Jiangsu Beijietai：Bemiltenase Alfa approved for marketing in China
Innovent：IBI343 has been formally accepted for review.
How much does Dupixent (Dupilumab Injection) Cost& price without insurance in China?
How much does Evrysdi (Risdiplam powder for oral solution) Cost& price without insurance in China?
How much does TEVIMBRA (Tislelizumab Injection) Cost& price without insurance in China?
How much does Akeega (Niraparib Tosylate and Abiraterone Acetate Tablets) Cost& price without insurance in China?
